Shandong Pharmaceutical Glass Co.Ltd (SHA: 600529)
China
· Delayed Price · Currency is CNY 25.24
-0.02 (-0.08%)
Nov 20, 2024, 10:27 AM CST
Shandong Pharmaceutical Glass Co.Ltd Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 5,088 | 4,937 | 4,130 | 3,820 | 3,390 | 2,952 | Upgrade
|
| Other Revenue | 45.68 | 45.68 | 56.82 | 55.53 | 37.2 | 40.79 | Upgrade
|
| Revenue | 5,133 | 4,982 | 4,187 | 3,875 | 3,427 | 2,992 | Upgrade
|
| Revenue Growth (YoY) | 5.36% | 18.98% | 8.05% | 13.08% | 14.53% | 15.77% | Upgrade
|
| Cost of Revenue | 3,578 | 3,618 | 3,090 | 2,789 | 2,358 | 1,945 | Upgrade
|
| Gross Profit | 1,555 | 1,364 | 1,098 | 1,086 | 1,069 | 1,047 | Upgrade
|
| Selling, General & Admin | 357.18 | 332.17 | 251.59 | 230.19 | 227.96 | 362.67 | Upgrade
|
| Research & Development | 159.9 | 137.95 | 138.94 | 135.63 | 133.87 | 126.86 | Upgrade
|
| Other Operating Expenses | 28.88 | 33.84 | 32.03 | 31.19 | 32.09 | 29.33 | Upgrade
|
| Operating Expenses | 550.32 | 515.37 | 434.56 | 407.88 | 407.25 | 520.12 | Upgrade
|
| Operating Income | 1,005 | 848.58 | 662.95 | 678.38 | 661.36 | 526.75 | Upgrade
|
| Interest Expense | -0.06 | -0.23 | -0.26 | -0.28 | -0.12 | -0.85 | Upgrade
|
| Interest & Investment Income | 38.52 | 44.11 | 16.74 | 17.47 | 33.03 | 43.45 | Upgrade
|
| Currency Exchange Gain (Loss) | 13.01 | 13.01 | 31.5 | -9.48 | -19.25 | 6.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 2.96 | -2.5 | -0.2 | -2.44 | -3.47 | -3.88 | Upgrade
|
| EBT Excluding Unusual Items | 1,060 | 902.97 | 710.73 | 683.64 | 671.56 | 571.54 | Upgrade
|
| Gain (Loss) on Sale of Investments | 25.74 | 22.83 | 3.73 | 9.26 | 0.5 | 1.84 | Upgrade
|
| Gain (Loss) on Sale of Assets | -11.67 | -12.24 | -3.51 | -22.7 | -27.21 | 3.49 | Upgrade
|
| Asset Writedown | -31.7 | -12.88 | -16.96 | -11.61 | -8.83 | -43.86 | Upgrade
|
| Other Unusual Items | 10.14 | 10.14 | 14.06 | 30.13 | 17.45 | 13.03 | Upgrade
|
| Pretax Income | 1,052 | 910.82 | 708.05 | 688.72 | 653.48 | 546.04 | Upgrade
|
| Income Tax Expense | 170.08 | 135.02 | 89.76 | 97.63 | 89.04 | 87.35 | Upgrade
|
| Earnings From Continuing Operations | 882 | 775.8 | 618.29 | 591.09 | 564.44 | 458.69 | Upgrade
|
| Net Income | 882 | 775.8 | 618.29 | 591.09 | 564.44 | 458.69 | Upgrade
|
| Net Income to Common | 882 | 775.8 | 618.29 | 591.09 | 564.44 | 458.69 | Upgrade
|
| Net Income Growth | 19.56% | 25.48% | 4.60% | 4.72% | 23.06% | 28.05% | Upgrade
|
| Shares Outstanding (Basic) | 663 | 663 | 600 | 597 | 594 | 596 | Upgrade
|
| Shares Outstanding (Diluted) | 663 | 663 | 600 | 597 | 594 | 596 | Upgrade
|
| Shares Change (YoY) | 1.74% | 10.46% | 0.54% | 0.49% | -0.26% | -0.22% | Upgrade
|
| EPS (Basic) | 1.33 | 1.17 | 1.03 | 0.99 | 0.95 | 0.77 | Upgrade
|
| EPS (Diluted) | 1.33 | 1.17 | 1.03 | 0.99 | 0.95 | 0.77 | Upgrade
|
| EPS Growth | 17.51% | 13.59% | 4.04% | 4.21% | 23.38% | 28.33% | Upgrade
|
| Free Cash Flow | 596.3 | 376.45 | -458.27 | -58.82 | 30.81 | 7.36 | Upgrade
|
| Free Cash Flow Per Share | 0.90 | 0.57 | -0.76 | -0.10 | 0.05 | 0.01 | Upgrade
|
| Dividend Per Share | 0.700 | 0.400 | 0.300 | 0.300 | 0.300 | 0.300 | Upgrade
|
| Dividend Growth | 133.33% | 33.33% | 0% | 0% | 0% | 39.99% | Upgrade
|
| Gross Margin | 30.30% | 27.38% | 26.21% | 28.03% | 31.18% | 34.98% | Upgrade
|
| Operating Margin | 19.58% | 17.03% | 15.83% | 17.51% | 19.30% | 17.60% | Upgrade
|
| Profit Margin | 17.18% | 15.57% | 14.77% | 15.25% | 16.47% | 15.33% | Upgrade
|
| Free Cash Flow Margin | 11.62% | 7.56% | -10.94% | -1.52% | 0.90% | 0.25% | Upgrade
|
| EBITDA | 1,352 | 1,173 | 958.13 | 919.03 | 879.26 | 695.85 | Upgrade
|
| EBITDA Margin | 26.34% | 23.55% | 22.88% | 23.71% | 25.66% | 23.25% | Upgrade
|
| D&A For EBITDA | 346.95 | 324.76 | 295.17 | 240.64 | 217.9 | 169.1 | Upgrade
|
| EBIT | 1,005 | 848.58 | 662.95 | 678.38 | 661.36 | 526.75 | Upgrade
|
| EBIT Margin | 19.58% | 17.03% | 15.83% | 17.51% | 19.30% | 17.60% | Upgrade
|
| Effective Tax Rate | 16.17% | 14.82% | 12.68% | 14.18% | 13.63% | 16.00% | Upgrade
|
| Revenue as Reported | 5,133 | 4,982 | 4,187 | 3,875 | 3,427 | 2,992 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.